Your browser doesn't support javascript.
loading
LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER Trial.
Sever, Peter; Gouni-Berthold, Ioanna; Keech, Anthony; Giugliano, Robert; Pedersen, Terje R; Im, KyungAh; Wang, Huei; Knusel, Beat; Sabatine, Marc S; O'Donoghue, Michelle L.
Afiliação
  • Sever P; National Heart and Lung Institute, Imperial College London, UK.
  • Gouni-Berthold I; Polyclinic for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Germany.
  • Keech A; NHMRC Clinical Trials Centre, University of Sydney, Australia.
  • Giugliano R; TIMI Study Group, Brigham and Women's Hospital and Harvard Medical School, USA.
  • Pedersen TR; Centre for Preventive Medicine, Ullevål University Hospital, Norway.
  • Im K; TIMI Study Group, Brigham and Women's Hospital and Harvard Medical School, USA.
  • Wang H; Clinical Development, Amgen Inc., USA.
  • Knusel B; Clinical Development, Amgen Inc., USA.
  • Sabatine MS; TIMI Study Group, Brigham and Women's Hospital and Harvard Medical School, USA.
  • O'Donoghue ML; TIMI Study Group, Brigham and Women's Hospital and Harvard Medical School, USA.
Eur J Prev Cardiol ; 28(8): 805-812, 2021 07 23.
Article em En | MEDLINE | ID: mdl-34298555
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pró-Proteína Convertase 9 / Anticolesterolemiantes Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pró-Proteína Convertase 9 / Anticolesterolemiantes Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido